FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Lidocaine Hydrochloride Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-lidocaine-hydrochloride-injection-hospira-inc-a-pfizer-company-0409-4903-34

Drug Shortage Details

Generic NameLidocaine Hydrochloride Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryAnesthesia, Pediatric
Availability StatusUnavailable
Status (FDA list)Current
NDC Package Code0409-4903-34
Presentation & Dosage Form

Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.